{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:54:37Z","timestamp":1787756077151,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10096-011-1380-1","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T13:12:05Z","timestamp":1315314725000},"page":"821-824","source":"Crossref","is-referenced-by-count":17,"title":["High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria"],"prefix":"10.1007","volume":"31","author":[{"given":"D. A.","family":"Williamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. T.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"1380_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","volume":"48","author":"R Bonnet","year":"2004","unstructured":"Bonnet R (2004) Growing group of extended-spectrum \u03b2-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1\u201314","journal-title":"Antimicrob Agents Chemother"},{"key":"1380_CR2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","volume":"35","author":"G Peirano","year":"2010","unstructured":"Peirano G, Pitout JD (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35:316\u2013321","journal-title":"Int J Antimicrob Agents"},{"key":"1380_CR3","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/AAC.00576-07","volume":"51","author":"JS Lewis","year":"2007","unstructured":"Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH (2007) First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob Agents Chemother 51:4015\u20134021","journal-title":"Antimicrob Agents Chemother"},{"key":"1380_CR4","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1128\/JCM.00319-09","volume":"47","author":"SE McGettigan","year":"2009","unstructured":"McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH (2009) Prevalence of CTX-M \u03b2-lactamases in Philadelphia, Pennsylvania. J Clin Micro 47:2970\u20132974","journal-title":"J Clin Micro"},{"key":"1380_CR5","volume-title":"Performance standards for antimicrobial susceptibility testing; CLSI document M100-S20","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2010","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; CLSI document M100-S20. CLSI, Wayne, PA"},{"issue":"4","key":"1380_CR6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/JCM.02322-06","volume":"45","author":"W Song","year":"2007","unstructured":"Song W, Bae IK, Lee YN et al (2007) Detection of extended-spectrum \u03b2-lactamases by using boronic acid as an AmpC \u03b2-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 45(4):1180\u20134","journal-title":"J Clin Microbiol"},{"key":"1380_CR7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2672.2004.02526.x","volume":"98","author":"SH Jeong","year":"2005","unstructured":"Jeong SH, Bae IK, Kwon SB et al (2005) Dissemination of transferable CTX-M-type extended-spectrum \u03b2-lactamase-producing Escherichia coli in Korea. J Appl Microbiol 98:921\u20137","journal-title":"J Appl Microbiol"},{"key":"1380_CR8","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antimicrobial wild type distributions of microorganisms. Home page at: http:\/\/www.escmid.org"},{"issue":"Suppl 1","key":"1380_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1469-0691.2007.01854.x","volume":"14","author":"M Gniadkowski","year":"2008","unstructured":"Gniadkowski M (2008) Evolution of extended-spectrum \u03b2-lactamases by mutation. Clin Microbiol Infect 14(Suppl 1):11\u201332","journal-title":"Clin. Microbiol Infect"},{"issue":"Suppl 6","key":"1380_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2005.01265.x","volume":"11","author":"D Andes","year":"2005","unstructured":"Andes D, Craig WA (2005) Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations. Clin Microbiol Infect 11(Suppl 6):10\u201317","journal-title":"Clin Microbiol Infect"},{"key":"1380_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","volume":"20","author":"J Turnidge","year":"2007","unstructured":"Turnidge J, Paterson DL (2007) Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 20:391\u2013408","journal-title":"Clin Microbiol Rev"},{"key":"1380_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/dkq449","volume":"66","author":"JA Roberts","year":"2011","unstructured":"Roberts JA, Kirkpatrick CM, Lipman J (2011) Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients. J Antimicrob Chemother 66:227\u2013231","journal-title":"J Antimicrob Chemother"},{"key":"1380_CR13","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/AAC.00063-08","volume":"52","author":"M Tumbarello","year":"2008","unstructured":"Tumbarello M, Sali M, Trecarichi EM et al (2008) Bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52:3244\u20133252","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1380_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","volume":"34","author":"A Wong-Beringer","year":"2002","unstructured":"Wong-Beringer A, Hindler J, Loeloff M et al (2002) Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Clin Infect Dis 34(2):135\u2013146","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1380-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1380-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1380-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:34:29Z","timestamp":1559108069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1380-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,6]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1380-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,6]]}}}